Vascular Regenerative Cell Exhaustion in Diabetes: Translational Opportunities to Mitigate Cardiometabolic Risk

Area of Science:

• Cardiovascular Science
• Endocrinology
• Regenerative Medicine

Background:

• Ischemic cardiovascular complications are a leading cause of mortality in type 2 diabetes (T2D).
• Individuals with T2D exhibit impaired tissue revascularization due to abnormal provascular progenitor cell production, termed 'regenerative cell exhaustion'.
• This exhaustion is exacerbated by oxidative stress, inflammation, and disease progression, potentially involving bone marrow microenvironment changes and Wnt signaling pathway dysregulation.

Purpose of the Study:

• To investigate the mechanisms underlying impaired vascular regeneration in type 2 diabetes.
• To explore potential therapeutic strategies for restoring vascular progenitor cell function and mitigating ischemic disease in T2D patients.

Main Methods:

• The study reviews the pathophysiology of impaired revascularization in T2D, focusing on progenitor cell dysfunction.
• It discusses the role of oxidative stress, inflammation, and the bone marrow microenvironment.
• Potential therapeutic interventions including antihyperglycemic agents, bariatric surgery, and exosomal manipulation are considered.

Main Results:

• Type 2 diabetes is associated with 'regenerative cell exhaustion', hindering the body's ability to repair ischemic tissues.
• Oxidative stress, inflammation, and bone marrow changes contribute to this cellular dysfunction.
• The Wnt signaling pathway may be a key regulator of progenitor cell pools affected in T2D.

Conclusions:

• Restoring vascular regenerative capacity is crucial for managing ischemic complications in type 2 diabetes.
• Therapeutic approaches targeting glucotoxicity, systemic inflammation, or utilizing exosomal modulation show promise.
• These strategies offer novel avenues for mitigating ischemic disease in the T2D population.